MY STOCKS Syndicate content

Sun Pharma to buy Glaxo's opiates business in Australia

Sun Pharmaceutical Industries Ltd, India's largest drugmaker by sales, said on Tuesday it has agreed to buy GlaxoSmithKline's opiates business in Australia to strengthen its pain management portfolio.

The business

L&T bags Rs 2,215-cr worth orders in last two months

Larsen & Toubro (L&T) today said it has bagged orders worth Rs 2,215 crore across various business segments in the last two months.
"L&T Construction has won orders worth Rs

Ranbaxy loses approvals, exclusivity of two drugs in US

Ranbaxy Laboratories' tentative approvals for its generic versions of digestive disorder drug Nexium and antiviral Valcyte along with 180-days marketing exclusivity stands canceled following a US court decision.

The DC

Titan begins production at new facility in TN

Watch manufacturing major Titan Company Ltd has began production of stainless steel cases at its new facility at Coimbatore in Tamil Nadu, set up an investment of Rs 75 crore.

Future Retail plans to raise up to Rs 1,500 cr

Future Retail plans to raise up to Rs 1,500 crore through debt instruments to replace high cost loans and to invest on brand building and marketing.
The company is seeking

BSE revises annual listing fee of companies for FY16

Top stock exchange BSE has revised its annual listing fees for companies listed on its platform for the next fiscal beginning April 1.
The exchange has also made changes to

Tata Power commissions first 63 mw unit of Bhutan hydro plant

Private power producer Tata Power has commissioned the first unit of its Dagachhu hydro power plant having a capacity of 63 MW in Bhutan.

"The company has commissioned 63 MW

STCI Finance invokes 1.76 shares in Bhushan Steel

Non-bank lender STCI Finance has invoked 1,76,000 shares in Bhushan Steel that were pledged by Bhushan Infrastructure in order to overcome losses from fall in stock prices in the last

Sun Pharma to buy GSK's Opiates business in Australia

Drug major Sun Pharma will acquire GlaxoSmithKline's Opiates business in Australia for an undisclosed amount.

"The acquisition is a part of our strategy towards building our portfolio of opiates and

Nifty rises to record high above 9000,Sensex at over 1month peak

Rising for the fourth session the benchmark Sensex today jumped 134. 59 points to end at over one-month high of 29 593

  • Temptation Foods to pledge 7 lakh shares

    Fruit processing firm Temptation Foods dipped nearly 9 per cent after the company on Monday said it would pledge its 7 lakh shares to one of its

  • Hirco postpones EGM amid resistance

    Giving in to the pressure from shareholders, Hirco, an investment vehicle of Mumbai-based realtor Hiranandani group, has adjourned its extraordinary

  • Tata Motors to raise up to Rs 2,700cr

    Tata Motors is looking at raising up to Rs 2,704.07 crore through public borrowing, offering up to 13.5 per cent returns, as it struggles to finance

  • Ashok Leyland bags $10.5m order

    Hinduja Group flagship company Ashok Leyland on Monday said it has bagged an order worth $10.5 million from the Honduras Armed Forces for 139

  • Exide Q3 net up marginally at Rs 56cr

    Battery maker Exide Industries said it has posted a net profit of Rs 56.15 crore during the third quarter ended December, as against Rs 55.16 crore

  • Kalam resigns from EMRI board

    Former President APJ Abdul Kalam has resigned from the governing board of Emergency Management Research Institute (EMRI), a non-profit organisation

Smart Chips
  • rel.jpg

    After a phase of correction, the counter once again saw buying of positions in Thursday’s sessions.

Lazy Chips
  • SUN.jpg

    The counter continued to see selling of positions in cash market as well as derivative segment.


FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

INTERVIEWS

William D. Green

Chairman & CEO, Accenture